to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study.
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
The effect of ruboxistaurin on nephropathy in type 2 diabetes.
Novel therapies of diabetic nephropathy.
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.